958851-01-9

Upstream product

• 958850-94-7 4-(4-chlorophenyl)-3-(3-bromophenyl)-2-butanol 
• 848310-98-5 3-(3-bromophenyl)-4-(4-chlorophenyl)butan-2-one 
• 958851-00-8 4-(4-chlorophenyl)-3-(3-cyanophenyl)-2-methylsulfonyloxybutane 

Downstream Products

• 732982-66-0 N-(1S,2S)-[2-(3-cyanophenyl)-3-(4-chlorophenyl)-1-methylpropyl]amine 
• 610791-48-5 N-(1S,2S)-[2-(3-cyanophenyl)-3-(4-chlorophenyl)-1-methylpropyl]amine hydrochloride 

Relevant academic research and scientific papers

SUBSTITUTED ESTERS AS CANNABINOID-1 RECEPTOR MODULATORS

Novel compounds of the structural formula (I) are antagonists and/or inverse agonists of the Cannabinoid-1 (CB1) receptor and are useful in the treatment, prevention and suppression of diseases mediated by the CB1 receptor. The compounds of the present in

RADIOLABELED CANNABINOID-1 RECEPTOR MODULATORS

The present invention relates to particular radiolabeled Cannabinoid-1 (CB1) receptor modulators, and methods of using these modulators for labeling and diagnostic imaging of Cannabinoid-1 receptors in mammals, particularly humans. In addition, intermediates useful for the synthesis of the radiolabeled Cannabinoid-1 receptor modulators are also disclosed, as well as the processes for synthesizing the radiolabeled Cannabinoid-1 receptor modulators. Still further, formulations of the radiolabeled Cannabinoid-1 receptor compounds are described.